Table 2. . Factors prognostic of overall survival of patients with intrahepatic cholangiocarcinoma treated with curative intent, as reported in the latest published series.
Study | Study period | Number of patients | Poor prognostic factors | Ref. | ||
---|---|---|---|---|---|---|
Not associated with overall survival | Univariate prognostic factors | Independent prognostic factors | ||||
De Jong et al. | 1973–2010 | 449 | Biliary invasion Direct invasion |
Large tumor size Multiple tumors Vascular invasion Lymph node metastasis |
Multiple tumors Vascular invasion Lymph node metastasis |
[22] |
Ribero et al. | 1990–2008 | 434 | Age Sex Serum CEA Tumor macroscopic type Perineural invasion Adjuvant treatment |
High serum CA 19-9 Poor tumor differentiation Lymph node metastasis Vascular invasion Large tumor size Multiple tumors Radical resection |
High serum CA 19-9 Lymph node metastasis Multiple tumors |
[12] |
Wang et al. | 2002–2007 | 367 | Age Sex Hepatitis B Vascular invasion Surgical margin (<1 versus ≥ 1) Presence of intact capsule Cirrhosis Microvascular invasion |
Elevated laboratory values (Serum CEA, CA 19–9, total bilirubin, albumin, GGT) Blood transfusion Large tumor size Multiple tumors Lymph node metastasis Vascular invasion Direct invasion Local extrahepatic metastasis |
High serum CEA and CA 19-9 Large tumor size Multiple tumors Lymph node metastasis Vascular invasion Direct invasion Local extrahepatic metastasis |
[75] |
Jiang et al. | 1998–2008 | 344 | Age Sex Hepatitis B Vascular invasion |
Low serum albumin High serum ALP and serum CA 19-9 Multiple tumors Large tumor size (≥10 cm) Obscure tumor boundary |
Multiple tumors Large tumor size Obscure tumor boundary High serum ALP and CA 19-9 |
[123] |
Farges et al. | 1998–2008 | 212 | NR | Pathologic TNM staging Large tumor size Satellite nodules Vascular invasion Lymph node metastasis R1 resection |
Pathologic TNM staging | [127] |
ALP: Alkaline phosphatase; CA: Carbohydrate antigen; CEA: Carcinoembryonic antigen; CN: China; FR: France; GGT: Gamma glutamyl transferase; ICC: Intrahepatic cholangiocarcinoma; IT: Italy; MC: Multicenter; MN: Multinational; NR: Not reported; OS: Overall survival.
Reproduced with permission from © American Medical Association (2016) [128].